CTMX 2.84 ▲ 17.84% Live Trading Data - Stocknear

CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
2.84
0.43 (17.84%)
At close: Sep 25, 2025, 3:59 PM
3.05
7.40%
After-hours: Sep 25, 2025, 05:31 PM EDT
17.84%
Bid 2.8
Market Cap 468.35M
Revenue (ttm) 141.1M
Net Income (ttm) 47.98M
EPS (ttm) 0.5
PE Ratio (ttm) 5.68
Forward PE -6.81
Analyst Buy
Dividends n/a
Ask 2.88
Volume 9,456,728
Avg. Volume (20D) 2,788,157
Open 2.36
Previous Close 2.41
Day's Range 2.33 - 2.86
52-Week Range 0.40 - 3.10
Beta 2.17
Ex-Dividend Date n/a

About CTMX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTMX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CTMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
CytomX Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.9%
CytomX Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
4 months ago
+4.93%
CytomX Therapeutics shares are trading higher after the company announced it dosed its first patient in the Phase 1 study of CX-801 plus KEYTRUDA.